Milberg Announces Securities Class Action Lawsuit Against Bone Biologics Corporation

  • Home
  • case
  • Milberg Announces Securities Class Action Lawsuit Against Bone Biologics Corporation
June 20, 2019

June 20, 2019

Milberg Phillips Grossman LLP has filed a class action lawsuit on behalf of holders of Bone Biologics Corporation (“BBLG”) common stock as of the occurrence of a change-of-control transaction (“Transaction”) undertaken in June of 2018. 

The complaint is filed in United States District Court for the District of Massachusetts (AFH Holding & Advisory et al v. Stroever et al., No. 1:18-cv-11612). It charges BBLG and certain of its officers and directors with violations of Section 14(c) of the Securities Exchange Act of 1934 and Rule 14c-6, as well as other state law causes of action including breach of fiduciary duty by BBLG’s directors and controlling stockholders, in connection with the Transaction. Plaintiffs seek damages on behalf of minority, non-controlling BBLG stockholders. 

Milberg Phillips Grossman LLP

Kent A. Bronson
(212)-594-5300
kbronson@milberg.com

Share